GDF2 and pulmonary arterial hypertension: However, Tu et al. [61] reported in 2019 that BMP9 knockout mice, or mice administrated with a neutralising anti-BMP9 antibody, were significantly protected against chronic hypoxia-induced pulmonary hypertension.